Spironolactone is not an effective treatment as the increased activity of the ENaC is not mediated by aldosterone (as reflected by the low plasma and urinary aldosterone levels). a Due to ...
Purpose: The clinical benefits, adverse effects, pharmacokinetics, and recommendations for the appropriate use of the aldosterone antagonists spironolactone and eplerenone in patients with heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback